7th November 2007
CRT Appoints Director of Discovery
16th October 2007
Breast Cancer diagnostic Markers Licensed by Perlegen in Agreement with University of Cambridge And Cancer Research Technology
11th September 2007
Novozymes, University College London and Cancer Research Technology conclude Collaboration Agreement
3rd September 2007
Vernalis receives milestone payment in Hsp90 inhibitor collaboration
28th August 2007
CRT Begins Critical Role in New Australian Cancer Research Venture
22nd August 2007
Antisoma’s ASA404 lung cancer trial will report positive survival data
21st August 2007
CRT Establishes Crystallography Facility at Birkbeck, University of London
17th July 2007
CRT and The Beatson Institute Announce Research Collaboration in Tumour Imaging with AstraZeneca
11th July 2007
Abiogen Licenses RFB4 Antibody from Cancer Research Technology
22nd June 2007
Cambridge Scientist Wins Innovation Award for Cancer Diagnostic Markers
20th June 2007
Cancer Research Technology Licenses Novel Toll-like Receptor Agents to Innate Pharma
4th June 2007
Cancer Research Technology and the University of Manchester Announce Biomarker Alliance with AstraZeneca
14th May 2007
Cancer Research Technology & Cronos Therapeutics extend scope of agreement
7th May 2007
Cancer Research Technology plans to expand Development Laboratories
2nd May 2007
Cancer Research Technology Licenses Therapeutic Antibodies to Peptech
19th April 2007
Antisoma Announces Global Agreement with Novartis for Cancer Drug AS1404
2nd April 2007
New CEO to Spearhead Laboratory Expansion at Cancer Research Technology
1st March 2007
Fox Chase Cancer Center and Cancer Research Technology Inc. Initiate Drug Discovery Collaboration
27th February 2007
Cancer Research Technology Secure Orphan Drug Designation for Fenretinide on Behalf of Cancer Research UK
6th February 2007
Progression of Checkpoint Kinase 1 Drug Discovery Programme
5th February 2007
Cancer Research Technology Grants Waypharm S.A.S Option to Novel Platinum Agents
30th January 2007
Formation of Australia’s First Cooperative Enterprise Dedicated to the Development of New Cancer Therapies
11th January 2007
Cancer Research Technology Announce Milestone following Initiation of Stimuvax® Phase 3 Trial in Non Small Cell Lung Cancer
|
